Breaking News, Promotions & Moves

Aera Therapeutics Appoints Paul Conrad Chief Business and Financial Officer

Dr. Conrad brings over 30 years of experience spanning R&D, strategy and operations, business and corporate development, alliance management, and finance.

By: Rachel Klemovitch

Assistant Editor

Aera Therapeutics, a biotechnology company, announced the appointment of Paul Conrad, Ph.D., MBA, as chief business and financial officer.  Dr. Conrad brings over 30 years of biopharma experience and expertise spanning R&D, strategy and operations, business and corporate development, alliance management, and finance. Akin Akinc, Ph.D., chief executive officer of Aera, said, “Paul is a seasoned biopharmaceutical executive, and his leadership will be key as we continue to build the compa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters